These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28133797)

  • 21. Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.
    Steichen JM; Phung I; Salcedo E; Ozorowski G; Willis JR; Baboo S; Liguori A; Cottrell CA; Torres JL; Madden PJ; Ma KM; Sutton HJ; Lee JH; Kalyuzhniy O; Allen JD; Rodriguez OL; Adachi Y; Mullen TM; Georgeson E; Kubitz M; Burns A; Barman S; Mopuri R; Metz A; Altheide TK; Diedrich JK; Saha S; Shields K; Schultze SE; Smith ML; Schiffner T; Burton DR; Watson CT; Bosinger SE; Crispin M; Yates JR; Paulson JC; Ward AB; Sok D; Crotty S; Schief WR
    Science; 2024 May; 384(6697):eadj8321. PubMed ID: 38753769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.
    Burton DR; Hangartner L
    Annu Rev Immunol; 2016 May; 34():635-59. PubMed ID: 27168247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction.
    Wiehe K; Saunders KO; Stalls V; Cain DW; Venkatayogi S; Martin Beem JS; Berry M; Evangelous T; Henderson R; Hora B; Xia SM; Jiang C; Newman A; Bowman C; Lu X; Bryan ME; Bal J; Sanzone A; Chen H; Eaton A; Tomai MA; Fox CB; Tam YK; Barbosa C; Bonsignori M; Muramatsu H; Alam SM; Montefiori DC; Williams WB; Pardi N; Tian M; Weissman D; Alt FW; Acharya P; Haynes BF
    Cell Host Microbe; 2024 May; 32(5):693-709.e7. PubMed ID: 38670093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native-like Env trimers as a platform for HIV-1 vaccine design.
    Sanders RW; Moore JP
    Immunol Rev; 2017 Jan; 275(1):161-182. PubMed ID: 28133806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
    Schiffner T; Phung I; Ray R; Irimia A; Tian M; Swanson O; Lee JH; Lee CD; Marina-Zárate E; Cho SY; Huang J; Ozorowski G; Skog PD; Serra AM; Rantalainen K; Allen JD; Baboo S; Rodriguez OL; Himansu S; Zhou J; Hurtado J; Flynn CT; McKenney K; Havenar-Daughton C; Saha S; Shields K; Schultze S; Smith ML; Liang CH; Toy L; Pecetta S; Lin YC; Willis JR; Sesterhenn F; Kulp DW; Hu X; Cottrell CA; Zhou X; Ruiz J; Wang X; Nair U; Kirsch KH; Cheng HL; Davis J; Kalyuzhniy O; Liguori A; Diedrich JK; Ngo JT; Lewis V; Phelps N; Tingle RD; Spencer S; Georgeson E; Adachi Y; Kubitz M; Eskandarzadeh S; Elsliger MA; Amara RR; Landais E; Briney B; Burton DR; Carnathan DG; Silvestri G; Watson CT; Yates JR; Paulson JC; Crispin M; Grigoryan G; Ward AB; Sok D; Alt FW; Wilson IA; Batista FD; Crotty S; Schief WR
    Nat Immunol; 2024 Jun; 25(6):1073-1082. PubMed ID: 38816615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
    Doria-Rose NA; Schramm CA; Gorman J; Moore PL; Bhiman JN; DeKosky BJ; Ernandes MJ; Georgiev IS; Kim HJ; Pancera M; Staupe RP; Altae-Tran HR; Bailer RT; Crooks ET; Cupo A; Druz A; Garrett NJ; Hoi KH; Kong R; Louder MK; Longo NS; McKee K; Nonyane M; O'Dell S; Roark RS; Rudicell RS; Schmidt SD; Sheward DJ; Soto C; Wibmer CK; Yang Y; Zhang Z; ; Mullikin JC; Binley JM; Sanders RW; Wilson IA; Moore JP; Ward AB; Georgiou G; Williamson C; Abdool Karim SS; Morris L; Kwong PD; Shapiro L; Mascola JR
    Nature; 2014 May; 509(7498):55-62. PubMed ID: 24590074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host controls of HIV broadly neutralizing antibody development.
    Kelsoe G; Haynes BF
    Immunol Rev; 2017 Jan; 275(1):79-88. PubMed ID: 28133807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage.
    Sacks D; Bhiman JN; Wiehe K; Gorman J; Kwong PD; Morris L; Moore PL
    PLoS Pathog; 2019 Sep; 15(9):e1008005. PubMed ID: 31479499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth.
    Roskin KM; Jackson KJL; Lee JY; Hoh RA; Joshi SA; Hwang KK; Bonsignori M; Pedroza-Pacheco I; Liao HX; Moody MA; Fire AZ; Borrow P; Haynes BF; Boyd SD
    Nat Immunol; 2020 Feb; 21(2):199-209. PubMed ID: 31959979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.
    Kepler TB; Wiehe K
    Immunol Rev; 2017 Jan; 275(1):129-144. PubMed ID: 28133793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development.
    Bonsignori M; Liao HX; Gao F; Williams WB; Alam SM; Montefiori DC; Haynes BF
    Immunol Rev; 2017 Jan; 275(1):145-160. PubMed ID: 28133802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.
    Landais E; Murrell B; Briney B; Murrell S; Rantalainen K; Berndsen ZT; Ramos A; Wickramasinghe L; Smith ML; Eren K; de Val N; Wu M; Cappelletti A; Umotoy J; Lie Y; Wrin T; Algate P; Chan-Hui PY; Karita E; ; ; Ward AB; Wilson IA; Burton DR; Smith D; Pond SLK; Poignard P
    Immunity; 2017 Nov; 47(5):990-1003.e9. PubMed ID: 29166592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HIV-1 envelope glycoprotein structure: nailing down a moving target.
    Ward AB; Wilson IA
    Immunol Rev; 2017 Jan; 275(1):21-32. PubMed ID: 28133813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design.
    Bonsignori M; Montefiori DC; Wu X; Chen X; Hwang KK; Tsao CY; Kozink DM; Parks RJ; Tomaras GD; Crump JA; Kapiga SH; Sam NE; Kwong PD; Kepler TB; Liao HX; Mascola JR; Haynes BF
    J Virol; 2012 Apr; 86(8):4688-92. PubMed ID: 22301150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
    Sadanand S; Suscovich TJ; Alter G
    Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for germline antibody recognition of HIV-1 immunogens.
    Scharf L; West AP; Sievers SA; Chen C; Jiang S; Gao H; Gray MD; McGuire AT; Scheid JF; Nussenzweig MC; Stamatatos L; Bjorkman PJ
    Elife; 2016 Mar; 5():. PubMed ID: 26997349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline-targeting immunogens.
    Stamatatos L; Pancera M; McGuire AT
    Immunol Rev; 2017 Jan; 275(1):203-216. PubMed ID: 28133796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An HIV Vaccine Targeting the V2 Region of the HIV Envelope Induces a Highly Durable Polyfunctional Fc-Mediated Antibody Response in Rhesus Macaques.
    Powell RL; Weiss S; Fox A; Liu X; Itri V; Jiang X; Luo CC; Spencer DA; Pandey S; Cheever T; Fuller DH; Totrov M; Hessell AJ; Haigwood NL; Kong XP; Zolla-Pazner S
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire.
    Altman PX; Ozorowski G; Stanfield RL; Haakenson J; Appel M; Parren M; Lee WH; Sang H; Woehl J; Saye-Francisco K; Joyce C; Song G; Porter K; Landais E; Andrabi R; Wilson IA; Ward AB; Mwangi W; Smider VV; Burton DR; Sok D
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.